Health & Fitness
Thu, March 29, 2012Wed, March 28, 2012Tue, March 27, 2012Mon, March 26, 2012Sun, March 25, 2012Sat, March 24, 2012Fri, March 23, 2012Thu, March 22, 2012Wed, March 21, 2012Tue, March 20, 2012Mon, March 19, 2012Sun, March 18, 2012Fri, March 16, 2012Thu, March 15, 2012Unilife to Host Analyst and Investor Day in New York on Wednesday, March 28th
Published in Health and Fitness on Thursday, March 22nd 2012 at 7:46 GMT by Market Wire
Unilife to Host Analyst and Investor Day in New York on Wednesday,... -- YORK, Pa., March 22, 2012 /PRNewswire/ --
Unilife to Host Analyst and Investor Day in New York on Wednesday, March 28th
Demonstrations of the Company's portfolio of advanced drug delivery systems
YORK, Pa., March 22, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: [ UNIS ]; ASX: UNS) announced today that it will host an Analyst and Investor Day on Wednesday, March 28th from 8:00am to 12:00pm ET in New York City.
Alan Shortall, Chief Executive Officer of Unilife, will give a brief introduction, and then Dr. Ramin Mojdeh, Chief Operating Officer at Unilife will moderate a series of presentations from several members of Unilife's management team. Company representatives will discuss converging market trends for injectable drug delivery, as well as provide an update on Unilife's device portfolio, commercial pipeline and business growth drivers. Presentations will be followed by a question and answer session.
The Company will also be giving demonstrations of its proprietary range of drug delivery systems including the Unifill prefilled syringe.
Space is limited, but analysts and investors interested in attending may RSVP by contacting Garth Russell at (212) 896-1250 or Jason Maymudes at (212) 896-1211.
About Unilife Corporation
Unilife Corporation (NASDAQ: [ UNIS ] / ASX: UNS) is a U.S. based developer and commercial supplier of advanced drug delivery systems. Unilife collaborates with pharmaceutical and biotechnology companies seeking innovative, differentiated devices that can enable or enhance the delivery of injectable drugs and vaccines supplied in either a liquid stable or lyophilized form. The Unifill syringe, the world's first and only prefilled syringe with fully integrated safety features, sits at the leading edge of this diversified portfolio. In addition to prefilled and hypodermic safety syringes with automatic, user-controlled needle retraction, Unilife has other proprietary technology platforms including drug reconstitution delivery systems, auto-injectors, auto-infusion pump systems and specialized devices for targeted organ delivery. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information on Unilife, please visit [ www.unilife.com ]
General: UNIS-G
Investor Contacts (US): | Analyst Enquiries | Investor Contacts (Australia) |
Todd Fromer / Garth Russell | Lynn Pieper | Jeff Carter |
KCSA Strategic Communications | Westwicke Partners | Unilife Corporation |
P: + 1 212-896-1215 / 212-896-1250 | P: + 1 415-202-5678 | P: + 61 2 8346 6500 |
SOURCE Unilife Corporation
[ Back to top ] RELATED LINKS
[ http://www.unilife.com ]
